Neurocritical expansion Target neurosurgical ICUs and high-acuity neurocritical care centers where IRRAflow can improve ICP management and reduce catheter blockages, presenting a compelling case for hospital adoption and protocol integration.

Digital enablement Leverage IRRAS’s software-enabled IRRAflow system to emphasize smart drainage, irrigation scheduling, and continuous monitoring as differentiators, appealing to hospitals seeking integrated data and remote performance visibility.

Geographic launches Prioritize regions with ongoing or recently completed product launches (Germany, broader Europe, and early US uptake) to accelerate market penetration, leveraging existing reference sites and clinical validation.

Affiliates growth Position IRRAS to attract and partner with distributors or regional sales affiliates in neurocritical care markets to expand reach, training, and service capability given the small internal team.

Clinical evidence Highlight the competitive advantage of reduced obstruction rates and proactive catheter flushing to drive discussions with hospital procurement while aligning with ongoing clinical education and protocol standardization.